免疫球蛋白在全身性硬化症管理中的作用. 一个大型的多中心体验
J Tandaipan1, A Guillén-Del-Castillo2, C P Simeón-Aznar2
1Department of Rheumatology and Systemic Autoinmune Diseases, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
Autoimmunity reviews
|September 14, 2023
概括
静脉注射免疫球蛋白 (IVIG) 治疗在改善系统性硬化症 (SSc) 患者的肌肉,皮肤和胃肠道症状方面显示出有前途. 这项研究表明IVIG是一种安全的治疗选择,用于在常规临床护理中管理SSc的表现.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,其特征是皮肤硬化和器官损伤.
- 目前SSc的治疗选择存在局限性,需要探索替代疗法.
- 静脉注射免疫球蛋白 (IVIG) 是一种免疫调节疗法,在自身免疫性疾病中具有潜在的应用.
研究的目的:
- 评估IVIG在治疗SSc.各种器官表现的疗效.
- 评估IVIG在SSc患者中的安全性和耐受性.
- 确定可能从IVIG治疗中受益最多的患者子组.
主要方法:
- 对接受IVIG治疗的SSc患者进行了回顾性多中心观察性研究.
- 数据收集包括流行病学参数,临床结果和不良事件.
- 评估的关键参数:修改的罗丹恩皮肤评分 (mRSS),肌肉强度 (MRC),肌酸激酶 (CK) 水平,以及胃肠道 (UCLA GIT 2.0) 和肺功能测试.
主要成果:
- 在IVIG后的肌肉参与 (MRC,CK水平) 和皮肤得分 (mRSS) 中观察到显著的改善.
- 在胃肠道症状得分 (UCLA GIT 2.0) 中发现了积极的趋势.
- IVIG 显示出良好的安全性,严重不良事件发生率较低.
结论:
- 在SSc患者中,IVIG可能是肌肉炎,胃肠道和皮肤表现的有效治疗方法.
- IVIG的安全性支持其在常规卫生保健中使用.
- 进一步的研究可能会为特定的SSc患者子组阐明最佳的IVIG协议.
更多相关视频
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Autoimmune Disorders
492
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
492
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
190
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
190


